Hester Biosciences Q4 Results: Stock jumps 14% after profit growth, strong operating performance

Hester Biosciences’ board has recommended a dividend of ₹11 per equity share for FY26, subject to shareholder approval at the upcoming annual general meeting.

Leave a Reply

Your email address will not be published. Required fields are marked *